The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical thawing system market reached a value of US$ XX Billion in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Medical thawing system defrosts biological samples for biology research, safe storage and transportation of biopharma products. It uses microprocessors to regulate temperature and perform cryopreserved ovum, semen, and embryo samples appropriately. At present, the increasing utilization of frozen plasma and blood products is catalyzing the demand for automated medical thawing systems worldwide. These systems assist in rapidly thawing live biological content to retain reproducibility and reduce the risk of contamination.
A considerable rise in the number of individuals suffering from chronic diseases and viral and bacterial infections represents one of the major factors driving the demand for blood transfusion and medical thawing systems. This can also be accredited to the growing participation of people in blood donation campaigns across the globe. In line with this, the widespread adoption of organ transplantation and increasing organ donors are propelling the market growth. Apart from this, the increasing geriatric population that undergoes surgical procedures is contributing to the need for tissue transplantation. This, in turn, is increasing the adoption of medical thawing systems to harvest and store skins, cornea, tendons, bone joints, Dura mater, and cartilage in tissue banks. Additionally, the coronavirus disease (COVID-19) outbreak has fueled the need for tissue banks to collect tissue specimens, understand cellular responses and the biological impact of infection, and identify new therapeutic interventions and prevention strategies. Besides this, the rising adoption of regenerative medicine and personalized treatment is propelling the use of medical thawing systems in biobanking worldwide. Furthermore, increasing investments in research and development (R&D) projects to find effective solutions that treat rare diseases are anticipated to bolster the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, sample type and end user.
Breakup by Product Type:
Breakup by Sample Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Sample Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at